Vaccines and monoclonal antibodies being developed for respiratory syncytial virus
A review of recent advancements in RSV immunoprophylactic measures, covering the landscape of vaccines and monoclonal antibodies in development to prevent respiratory syncytial virus infections in infants, pregnant women, and older adults.